| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/07/2010 | WO2009066245A3 Thomsen-friedenreich disaccharide modified immunogen (tfd), preparation procedure, compositions comprising it, uses, and treatment methods |
| 01/07/2010 | WO2009014638A3 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 01/07/2010 | WO2009008916A3 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 01/07/2010 | WO2008153962A3 Method of reducing tissue loss in pancreatic islet cell transplantation |
| 01/07/2010 | WO2008097870A3 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 01/07/2010 | US20100005536 Promoter for Introducing a Gene into a Lymphocyte or Blood Cell and Application Thereof |
| 01/07/2010 | US20100004430 Peptide-based immunization therapy for treatment of atherosclerosis |
| 01/07/2010 | US20100004276 Vitamin receptor binding drug delivery conjugates |
| 01/07/2010 | US20100003333 Compositions and methods for treating digestive disorders |
| 01/07/2010 | US20100003324 Vinpocetine and eburn amonine derivatives for promoting bone growth |
| 01/07/2010 | US20100003316 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep) |
| 01/07/2010 | US20100003288 comprising an immunostimulatory oligodeoxynucleotide having a plurality of TCG tandem repeats at a 5' end, a poly-G structure at a 3' end, and at least one CpG motif with avian specific flanking sequences at two ends thereof between the 5' end and the 3' end |
| 01/07/2010 | US20100003287 Compositions and Methods Relating to Treatment of Cancer and Infectious Diseases |
| 01/07/2010 | US20100003286 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 01/07/2010 | US20100003285 Human Hookworm Vaccine |
| 01/07/2010 | US20100003284 Live attenuated aldolase-negative bacterial vaccine |
| 01/07/2010 | US20100003283 Lipid a deficient mutants of neisseria meningitidis |
| 01/07/2010 | US20100003282 Systems and methods for delivery of a therapeutic agent |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003279 Vaccine for in ovo inoculation |
| 01/07/2010 | US20100003278 Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof |
| 01/07/2010 | US20100003277 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 01/07/2010 | US20100003276 Methods for treating anthrax and inhibiting lethal factor |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003272 Method for Expanding Monocytes |
| 01/07/2010 | US20100003271 Nitric oxide increases switching of t cells into t regulatory cells |
| 01/07/2010 | US20100003270 Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments |
| 01/07/2010 | US20100003269 Methods and uses of cauliflower and collard for recombinant protein production |
| 01/07/2010 | US20100003268 Therapy of Malignant Neoplasias |
| 01/07/2010 | US20100003267 Anti-angiogenic compounds |
| 01/07/2010 | US20100003266 Targeted immune conjugates |
| 01/07/2010 | US20100003265 Isolation, expansion and uses of tumor stem cells |
| 01/07/2010 | US20100003264 Reduction of Ophthalmalogic Neovascularization |
| 01/07/2010 | US20100003263 Monoclonal antibodies to anthrax protective antigen |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
| 01/07/2010 | US20100003260 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 01/07/2010 | US20100003257 Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion |
| 01/07/2010 | US20100003256 Use of TGF-Beta Antagonists in Treatment of Parathyroid-Related Disorders |
| 01/07/2010 | US20100003255 Gene expression pattern predictive for colorectal carcinomas |
| 01/07/2010 | US20100003254 Antibody Substituting for Function of Blood Coagulation Factor VIII |
| 01/07/2010 | US20100003253 Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| 01/07/2010 | US20100003252 Blocking immune response to a graft |
| 01/07/2010 | US20100003251 Uses of IL-23 Agonists and Antagonists; Related Reagents |
| 01/07/2010 | US20100003250 (2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003247 Assay for metastatic colorectal cancer |
| 01/07/2010 | US20100003246 Novel heterocyclic compounds and uses therof |
| 01/07/2010 | US20100003245 Remedy for Renal Disease |
| 01/07/2010 | US20100003244 Agents which bind to epitopes of glycoprotein vi |
| 01/07/2010 | US20100003243 Uses and Compositions for treatment of Psoriasis and Crohn's Disease |
| 01/07/2010 | US20100003242 antibody that binds sphingosine-1-phosphate (S1P); used for detection of S1P or for treatment of diseases and conditions associated with S1P |
| 01/07/2010 | US20100003241 Agents for treatment or prevention of an allergic disorder |
| 01/07/2010 | US20100003240 Cancer treatment with endothelin receptor antagonists |
| 01/07/2010 | US20100003239 Anti-hedgehog antibodies |
| 01/07/2010 | CA2729868A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | CA2729818A1 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides |
| 01/07/2010 | CA2729793A1 Msp-1 protein preparations from plasmodium |
| 01/07/2010 | CA2729775A1 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729749A1 Tnf-a antagonist multi-target binding proteins |
| 01/07/2010 | CA2729747A1 Il6 immunotherapeutics |
| 01/07/2010 | CA2729591A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 01/07/2010 | CA2729567A1 Anti-cd27 antibody |
| 01/07/2010 | CA2729499A1 Anti-gd2 antibodies and methods and uses related thereto |
| 01/07/2010 | CA2729404A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device |
| 01/07/2010 | CA2729403A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 01/07/2010 | CA2729151A1 Modification of allergens for immunotherapy |
| 01/07/2010 | CA2729080A1 Cattle vaccines |
| 01/06/2010 | EP2141227A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 01/06/2010 | EP2141177A1 MSP-1 protein preparations from Plasmodium |
| 01/06/2010 | EP2140884A1 A vaccine preventing and/or treating autoimmune diseases |
| 01/06/2010 | EP2140881A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/06/2010 | EP2140880A1 Modification of allergens |
| 01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
| 01/06/2010 | EP2140878A1 Vaccine against streptococcus pneumoniae |
| 01/06/2010 | EP2140877A1 New use of coccidian |
| 01/06/2010 | EP2140873A1 Method for producing an antitumoral vaccine based on surface endothelial cell antigens |
| 01/06/2010 | EP2140005A1 Antagonists of ligands and uses thereof |
| 01/06/2010 | EP2139923A1 Modulation of tumor microenvironment |
| 01/06/2010 | EP2139922A1 Treatment of hodgkins lymphoma |
| 01/06/2010 | EP2139917A2 Anti-androgen peptides and uses thereof in cancer therapy |
| 01/06/2010 | EP2139916A1 Toll-like receptor binding epitope and compositions for binding thereto |
| 01/06/2010 | EP2139913A2 Inducing immune-mediated tumor cell death |
| 01/06/2010 | EP2139516A1 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 01/06/2010 | EP2139515A2 Attenuated viruses useful for vaccines |
| 01/06/2010 | EP2139514A1 Artificial invaplex |
| 01/06/2010 | EP2139513A1 Polymer particles based vaccine |
| 01/06/2010 | EP2139497A2 Methods for treating nervous system injury and disease |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1432722B1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/06/2010 | EP1409018B1 Stable lyophilized pharmaceutical formulation the igg antibody daclizumab |
| 01/06/2010 | EP1355944B1 Rtvp based compositions and methods for the treatment of prostate cancer |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/06/2010 | CN101622011A Methods of releasing sporocysts from oocysts using controlled shear forces |